PPT-Optimal Management of Anticoagulant Therapy

Educational Slides Set American Society of Hematology 2021 Authors Mario Luis Tejerina Valle MD Caja Petrolera de Salud Bolivia Juan Carlos Serrano Casas MD Universidad Central de Venezuela . How long to treat a DVT?. What do the ACCP Guidelines say?. Duration of Long-term Anticoagulant Therapy. In patients with a proximal DVT of the leg provoked by surgery, we recommend treatment with anticoagulation for 3 months over (i) treatment of a shorter period . Ray P. . Aswat. , M.D.. Adult Cardiology Fellow. Background. Coronary Artery Bypass Graft (CABG) is recommended for patients with left main disease and the preferred revascularization strategy for patients with multi-vessel coronary disease, with depressed systolic function, Left Ventricular Ejection Fraction (LVEF) < 50%, and diabetes.. Sponsor: Dr. K.C. Chang. Tony Chen. Ehsan Esmaeilzadeh. Ali Jarvandi. Ning Lin. Ryan O’Neil. Spring 2010. Outline. Background & Problem Statement. Project Scope. Requirements. Assumptions. Approach. Sponsor: Dr. K.C. Chang. Tony Chen. Ehsan Esmaeilzadeh. Ali Jarvandi. Ning Lin. Ryan O’Neil. Spring 2010. Outline. Background. Optimal Option Investment Strategy Team. Problem Statement. Statement of Need. FCC Task Force on Optimal PSAP Architecture. Working Group 1 Final Report . December 10. th. , 2015. Report Outline. Objective. , Scope, and . Methodology. Section 1 – . Cybersecurity . Today. Section 2 – Best Practices. Keith Dalbey, Ph.D.. Sandia National Labs, Dept 1441, Optimization and Uncertainty Quantification. Michael Levy, Ph.D.. Sandia National Labs, Dept 1442, Numerical Analysis and Applications. Sandia is a multiprogram laboratory operated by Sandia Corporation, a Lockheed Martin Company, for the United States Department of Energy’s National Nuclear Security Administration under Contract DE-AC04-94AL85000.. Andrew B. . Kahng. and . Siddhartha . Nath. VLSI CAD LABORATORY, UC San Diego. Outline. Motivation. Previous Work. Our Work. Problem Formulation. Optimal (Discretized) Solution Flow. Results. Conclusions. An Educational Slide Set . American Society of Hematology 2018 Guidelines . for Management of Venous Thromboembolism. Slide set authors: . E. ric. Tseng MD . MScCH. , University of Toronto. Daniel Witt PharmD, University of Utah. :. are additives that inhibit clotting of blood and/or plasma. They act either by binding calcium ions or by inhibiting thrombin activity. . Platelets and coagulation factors are activated when blood vessels are punctured, and their activation continues in sample containers that do not contain anticoagulant, leads to clot formation which interfere with many analytical tests.. Anticoagulant therapy. (n = . 124). CADISS. P. rimary outcome. : . Ipsilateral . stroke or all-cause mortality . for antiplatelet vs. anticoagulation: 2. % . vs. 1%; p . = . 0.63. Any stroke: 2% vs. 1%, . existing clots from growing larger. Although anticoagulants are sometimes called blood thinners , they do not actually thin the blood. The job of anticoagulants is to promote the smooth flow of bloo Presented by-. Dr. Varun Mittal, PG. Dept of Maxillofacial Surgery. SRM DENTAL COLLEGE, CHENNAI, INDIA. Which all patients?. Mostly cardiac or vascular disorders:. Atrial. fibrillation. Ischemic cardiac disease. 2 primary functions of vein are transporting blood toward the heart and . serving as reservoir . to prevent intravascular volume overload.. Venous endothelium is . non- thrombogenic surface. .. Unidirectional blood flow is achieved with multiple venous valves.. Josh Smith. Overview. Adverse Drug Reactions. Toxicities. Adverse Drug Reaction. Type A Adverse drug reaction. Dose dependent . Preventable. Type B ADR. Idiosyncratic. Multifactorial. Underlying disease (kidney or liver dysfunction).